References
  1. Zarychanski R and Houston DS. Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response? CMAJ. 2008;179(4):333-7.
  2. Thomsen SF. Epidemiology and natural history of atopic diseases. Eur Clin Respir J. 2015;2:10.
  3. Wouters EFM, Reynaert NL, Dentener MA, et al. Systemic and Local Inflammation in Asthma and Chronic Obstructive Pulmonary Disease: Is There a Connection? Proc Am Thorac Soc. 2009;6:638-47.
  4. Drury KE, Schaeffer M, Silverberg JI. Association Between Atopic Disease and Anemia in US Children. JAMA Pediatr. 2016;170:29-34.
  5. Rhew K, Brown JD, Oh JM. Atopic Disease and Anemia in Korean Patients: Cross-Sectional Study with Propensity Score Analysis. Int J Environ Res Public Health. 2020;17:1978
  6. Kim L, Kim JA, Kim S. A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples. Epidemiol Health. 2014;36:e2014008.
  7. Allali S, Brousse V, Sacri AS, et al. Anemia in children: prevalence, causes, diagnostic work-up, and long-term consequences. Expert Rev Hematol. 2017;10:1023-8.
  8. Milman N.Iron prophylaxis in pregnancy—General or individual and in which dose? Ann Hematol. 2006;85:821-8.
  9. Nairz M, Weiss G. Infections Associated with Iron Administration. Met Ions Life Sci. 2019;19
  10. Poggiali E, De Amicis MM, Motta I. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases. Eur J Intern Med. 2014;25:12-7.
  11. Theurl M, Nairz M, Schroll A, et al. aHepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats. Haematologica. 2014;99:1516-24.
  12. Bregman DB, Morris D, Koch TA, et al. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol. 2013;88:97-101.